TSLP and Alzheimer disease: Thymic stromal lymphopoietin (TSLP), a cytokine highly expressed in the epidermis of patients with AD and known to promote Th2 immune responses [70], was also significantly downregulated following AMP-IBP5 treatment in the lesional skin of AD mice.